Transurethral microwave therapy [TUMT] for benign prostatic hyperplasia ; our experience

ABSTRACT

Minimally invasive office -based treatment for benign prostatic hyperplasia [BPH] are challenging the traditional surgical and medical management options for symptomatic BPH. The aim of this study is to assess the efficacy of transurethral microwave therapy [TUMT] on spontaneous voiding, maximum flow rate and residual urine volume in patients with otherwise poor general health and BPH. Thirty [30] patients with associated comorbid diseases and retention of urine [acute and chronic] due to BPH were subjected for TUMT as an outpatient procedure, from January 2002 to November 2003. Follow up was performed 10 days post TUMT, and then monthly until 3 months clinically and by assessing, spontaneous voiding, maximal flow rate and residual urine volume. Out of 30 treated patients, 5 were able to void spontaneously [without catheter] at the end of 12 weeks following TUMT. There was a little improvement of maximum urinary flow rate and residual urine volume at the end of the same period. TUMT is an alternative choice for the treatment of patients with BPH and chronic medical illnesses or those refusing surgery. However low energy protocol TUMT is not an effective treatment mode for patients with urinary retention due to BPH